President Trump is expected to call for an end to HIV transmission by 2030. The drug known as PrEP may be key.
The giant multinational corporation Bayer is selling off the Dr. Scholl’s and Coppertone brands acquired four years ago when the company bought Merck. Now Bayer is looking to expand its cancer drug research and development and the agribusinesses it’s been…
It's "really about returning excess profits," a Kaiser Family Foundation executive says.
Drug companies can get creative with doctor incentives, and that can be problematic.
The Food and Drug Administration is trying to help mitigate the shortage of EpiPens, those auto-injecting devices used to treat allergic reactions to things like peanuts and bee stings. It’s extended by four months the expiration date for some EpiPen…
Will this be the catalyst for big pharmaceutical companies to get into the pot business?
Kaiser joins other healthcare organizations investing in affordable housing.
Several health economists and policy experts argue until Washington forces drug companies to lower their overall prices, an out-of-pocket Medicare cap is just dabbling at the edges.
More hospitals across the country are selling debt from unpaid medical bills to collection agencies.
With access to Aetna's 47 million customers, CVS wants to transform its stores into "health care hubs."